Dr. Leon I. Kupferwasser, MD

Dr. Kupferwasser practices at The Heart Medical Group in Sherman Oaks, California.

Dr. Kupferwasser's NPI, 1316067457, was assigned on March 30, 2007. Dr. Kupferwasser graduated from Johannes Gutenberg University of Mainz Faculty of Medicine in 1991. Dr. Kupferwasser holds California license A83900.

Dr. Kupferwasser's primary practice is The Heart Medical Group, at 4835 N Van Nuys Blvd, Sherman Oaks, CA 91403 in Los Angeles County. The practice phone is (818) 904-6782.

Dr. Kupferwasser's primary practice is The Heart Medical Group in Sherman Oaks, California. Dr. Kupferwasser is also affiliated with Providence Cedars-Sinai Tarzana Medical Center. The medical group on file is The Heart Medical Group. Dmand AI also links Dr. Kupferwasser to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kupferwasser practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Kupferwasser's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Kupferwasser is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Kupferwasser is licensed in California.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cardiomyopathy, cerebrovascular disease, chronic hypertension, chronic skin ulcer, coronary artery disease and heart blockage among the conditions Dr. Kupferwasser treats.

CMS data shows 16,900 Medicare services from Dr. Kupferwasser across 30 procedure codes in 2024, for 1,865 Medicare patients. Medicare paid $846,406 for them.

CMS counts 1,865 Medicare patients who saw Dr. Kupferwasser in 2024. The largest group is 65 to 74, with 810 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 58% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kupferwasser's median patient age at 67, with 49% women.

In 2024, Dr. Kupferwasser wrote 8,247 Medicare Part D claims for 1,262 patients. 84% of them were for generic drugs. CMS names the drug for 8,021 of them, across 63 drugs with 11 or more claims each, at $1,407,670 in total drug cost. In 2023, CMS named 7,065 claims across 59 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Kupferwasser for performance year 2024, reported as part of a group. Dr. Kupferwasser accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kupferwasser as offering telehealth.

Dmand AI links 14 papers to Dr. Kupferwasser in 2008. The most frequent topics are Rabbits, Endocarditis, Bacterial and Microbial Sensitivity Tests. Dr. Kupferwasser has published most often in Antimicrob Agents Chemother. Dr. Kupferwasser's most frequent co-authors are Allen M. Amorn, MD, Bojan Cercek, MD and Suhail Y. Dohad, MD.

CMS Open Payments shows 563 general payments to Dr. Kupferwasser from 45 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Amgen Inc. paid the most, $1,805.

Dr. Kupferwasser graduated from Johannes Gutenberg University of Mainz Faculty of Medicine in 1991.

Dr. Kupferwasser is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.